GE

Gabriela Ecco

Board Member at Notify Therapeutics

Lausanne, Vaud

Overview 

Gabriela Ecco is a Senior Associate at +ND Capital in Lausanne, Vaud, with expertise in sourcing, due diligence, project management, and bioinformatics. With a background in venture capital and a strong focus on sectors like Pharmaceuticals and BioTech, she has held roles such as Board Observer at various biotech companies and has a notable educational background including a PhD from EPFL. Gabriela has excelled in her career by serving as a Board Observer for several biotech companies and has demonstrated a deep understanding of venture capital investments, particularly in sectors like Pharmaceuticals and BioTech. Currently, as a Senior Associate at +ND Capital, she continues to leverage her skills in sourcing, due diligence, and project management to drive success in the industry.

Work Experience 

+C

+ND Capital

  • Principal

    2025 - Current

  • Senior Associate

    2023 - 2025

  • Associate

    2021 - 2022

  • Innovation Fellow

    2021 - 2021

NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.

nd.capital
CB

Constructive Bio

  • Board Observer

    2025

T

Timeline®

  • Board Observer

    2024

NT

Notify Therapeutics

  • Board Observer

    2023

A

AIRNA

  • Board Observer

    2022

VS

Vandria SA

  • Board Observer

    2021

EVIR Therapeutics

  • Board Observer

    2021

Osasuna Therapeutics

  • Board Observer

    2022 - 2025

C

CellPoint

  • Board Observer

    2021 - 2022

SG

SOPHiA GENETICS

  • Genomics Research Expert

    2020 - 2021

    - Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.

  • Senior NGS Scientist

    2019 - 2020

    - Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.

  • NGS Scientist

    2016 - 2019

    - Coordinated and participated in different projects to develop products for precision medicine and molecular diagnostics in oncology. - Performed on-site customer trainings in Europe and South America and provided internal and external technical support.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Raised $265,152,150.00 from Perceptive Advisors.

sophiagenetics.com

Education 

Articles About Gabriela

Relevant Websites